GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangxi Synergy Pharmaceutical Co Ltd (SZSE:300636) » Definitions » COGS-to-Revenue

Jiangxi Synergy Pharmaceutical Co (SZSE:300636) COGS-to-Revenue : 0.72 (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Jiangxi Synergy Pharmaceutical Co COGS-to-Revenue?

Jiangxi Synergy Pharmaceutical Co's Cost of Goods Sold for the three months ended in Mar. 2025 was ¥135.3 Mil. Its Revenue for the three months ended in Mar. 2025 was ¥186.9 Mil.

Jiangxi Synergy Pharmaceutical Co's COGS to Revenue for the three months ended in Mar. 2025 was 0.72.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Jiangxi Synergy Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2025 was 27.58%.

Jiangxi Synergy Pharmaceutical Co COGS-to-Revenue Historical Data

The historical data trend for Jiangxi Synergy Pharmaceutical Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangxi Synergy Pharmaceutical Co COGS-to-Revenue Chart

Jiangxi Synergy Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.65 0.70 0.68 0.67 0.67

Jiangxi Synergy Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 0.68 0.68 0.69 0.72

Jiangxi Synergy Pharmaceutical Co COGS-to-Revenue Calculation

Jiangxi Synergy Pharmaceutical Co's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=508.368 / 758.89
=0.67

Jiangxi Synergy Pharmaceutical Co's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=135.348 / 186.898
=0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangxi Synergy Pharmaceutical Co  (SZSE:300636) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Jiangxi Synergy Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 135.348 / 186.898
=27.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Jiangxi Synergy Pharmaceutical Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Jiangxi Synergy Pharmaceutical Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangxi Synergy Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangxi Synergy Pharmaceutical Co Ltd (SZSE:300636) » Definitions » COGS-to-Revenue
Comparable Companies
SZSE:002107 SHSE:603538 SZSE:300239 SZSE:300683 SHSE:600594 SHSE:600222 SZSE:300016 SHSE:688221 SHSE:603811 SZSE:301201 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
Fengxin Industrial Park, Fengxin, Jiangxi Province, Yichun, CHN, 330700
Website
http://www.jxsynergy.com
Jiangxi Synergy Pharmaceutical Co Ltd is a China-based company that engages in the production of bulk drugs and intermediates. Its main products include anti-epileptic medicines, anti-ulcer medicines, anti-pyretic analgesics, non-steroid anti-inflammatory analgesics, anti-high blood pressure medicines, and anti-depression drugs.
Executives
Pang Zheng Wei Directors, executives
Huang Guo Jun Directors, executives
Liang Zhong Cheng Directors, executives
Jiang Yuan Sen Directors, executives
Yu Shao Jiong Supervisors
Zhang Bo Securities Affairs Representative
Jiang Hui Gang Director
Wang Xiao Hua Director
Zhao Hong Liang Director

Jiangxi Synergy Pharmaceutical Co Headlines

No Headlines